“…The present study examined the effect of TCDD on AhR, HNF4α and COUP-TFII genomic binding with subsequent effects on the expression of genes associated with liver function and hepatocyte differentiation. As a potent AhR agonist, TCDD dysregulates a plethora of hepatic functions in rodents including lipoprotein assembly and export metabolism (Angrish et al, 2013;Nault et al, 2017b), bile acid homeostasis (Fader et al, 2017b;Forgacs et al, 2012), cholesterol metabolism (Angrish et al, 2013;Nault et al, 2017b), lipid metabolism (Angrish et al, 2013;Cholico et al, 2021;Nault et al, 2017b), glucose metabolism (Fader et al, 2019;Nault et al, 2016aNault et al, , 2016b, iron and heme homeostasis (Fader et al, 2017a), one-carbon metabolism (Fling et al, 2020), and cobalamin-dependent reactions (Orlowska et al, 2021). Previous studies have established that the activated AhR can bind to DNA motif as a heterodimer with ARNT and associated with other transcription factors such as COUP-TF, HIF, HNF4, LRH1, NRF1, PPAR, and RXR (Dere et al, 2011).…”